Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Clin Pharmacol ; 69(4): 937-48, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23052416

RESUMO

PURPOSE: We assessed the prevalence of difficulties in swallowing solid oral dosage forms in a general practice population. Reasons, nature, and characteristics of tablets and capsules causing such difficulties were investigated as well as general practitioners' (GP) awareness of these difficulties. METHODS: A questionnaire survey was conducted in 11 general practices and consecutive patients taking at least one solid oral dosage form for ≥4 weeks were invited to respond to a questionnaire at the practices and one at home. Physicians completed a short questionnaire for each included patient. RESULTS: Of all participants (N = 1,051), 37.4 % reported having had difficulties in swallowing tablets and capsules. The majority (70.4 %) of these patients was not identified by their GP. The occurrence of swallowing difficulties was related to gender (f>m), age (young>old), dysphagia [adjusted odds ratio (adOR): 7.9; p < 0.0001] and mental illness (adOR: 1.8; p < 0.05). By asking "Do you choke while eating or drinking?", affected patients could be identified with a sensitivity of 62.6 % and a specificity of 78.1 %. Because of these difficulties, 58.8 % of the affected patients had already modified their drugs in a way that may alter safety and efficacy and 9.4 % indicated to be non-adherent. CONCLUSIONS: One in 11 primary care patients had frequent difficulties in swallowing tablets and capsules while GPs grossly underestimated these problems. Therefore, physicians should rule out swallowing difficulties regularly to avoid non-adherence and inappropriate drug modifications. Special attention should be paid to specific patient groups (e.g. women and patients with dysphagia, dysphagia indicators, or mental illness).


Assuntos
Cápsulas/normas , Deglutição , Medicina Geral , Cooperação do Paciente/estatística & dados numéricos , Comprimidos/normas , Administração Oral , Cápsulas/química , Transtornos de Deglutição/epidemiologia , Transtornos de Deglutição/fisiopatologia , Feminino , Medicina Geral/estatística & dados numéricos , Humanos , Masculino , Transtornos Mentais/epidemiologia , Transtornos Mentais/fisiopatologia , Pessoa de Meia-Idade , Fatores de Risco , Propriedades de Superfície , Inquéritos e Questionários , Comprimidos/química
2.
Patient Prefer Adherence ; 6: 679-84, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23055701

RESUMO

BACKGROUND: The aim of this pilot study was to evaluate patients' self-reported attitudes towards medication-related factors known to impair adherence and to assess their prevalence in ambulatory care as an essential prerequisite to improve patient adherence. METHODS: We conducted a face-to-face interview with 110 primary care patients maintained on at least one drug. For each drug, the patient was asked to specify medication-related factors of interest, ie, dosage form, dosage interval, required relationship with food intake, and the planned time of day for intake, and to rate the individual relevance of each prevalent parameter on a three-point Likert scale (discriminating between prefer, neutral, and dislike). RESULTS: Tablets with a once-daily dosage frequency were the most preferred dosage form, with a high prevalence in the ambulatory setting. Drug intake in the morning and evening were most preferred, and drug intake at noon was least preferred, but also had a low prevalence in contrast with drug intake independent of meals that was most preferred. Interestingly, only one quarter (26.4%) of all the patients were able to indicate clear preferences or dislikes. CONCLUSION: When patients are asked to specify their preferences for relevant medication regimen characteristics, they clearly indicated regimens that have been associated with better adherence in earlier studies. Therefore, our results suggest that adaptation of drug regimens to individual preferences might be a promising strategy to improve adherence. Because the German health care system may differ from other systems in relevant aspects, our findings should be confirmed by evaluation of patient preferences in other health care systems. Once generalizability of the study results is shown, these findings could be a promising basis upon which to promote patient adherence right from the beginning of drug therapy.

3.
Naunyn Schmiedebergs Arch Pharmacol ; 376(1-2): 135-43, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17653693

RESUMO

Several studies have demonstrated that the adenosine triphosphate-binding cassette transporter P-glycoprotein (P-gp) is at least partly located in cholesterol- and sphingolipid-enriched parts of the plasma membrane called "lipid rafts" and that modification of cellular cholesterol content has an impact on the activity of P-gp in vitro and ex vivo. Cholesterol modulation in vitro does not closely reflect the in vivo situation. The aim of our study was therefore to investigate whether differences in individual plasma low-density lipoprotein (LDL) cholesterol levels in humans have an impact on cholesterol content in peripheral blood mononuclear cells (PBMCs) and thereby on individual activity of P-gp. PBMCs of 20 ambulatory patients with elevated LDL cholesterol (173.9 +/- 22.4 mg/dl; range 151.0-234.4 mg/dl) and 28 controls (125.2 +/- 16.9 mg/dl; range 74.6-149.6 mg/dl) were isolated. Cellular cholesterol was measured by an enzymatic fluorimetric assay, efflux activity of P-gp in PBMCs was determined by a flow cytometric method (rhodamine123 efflux), and messenger ribonucleic acid expression was quantified by reverse transcriptase real-time polymerase chain reaction (RT-PCR). There was no difference in cellular cholesterol or P-gp activity between the two groups suggesting that high plasma LDL cholesterol concentration as observed in dyslipidemic patients does not correlate with cellular cholesterol content or P-gp activity in PBMCs. There was, however, a significant negative relationship between age and P-gp efflux activity indicating that P-gp activity in PBMCs decreases with advancing age. These results need further confirmation because investigation of age dependency of P-gp activity was not the primary aim of the study.


Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/sangue , LDL-Colesterol/sangue , Leucócitos Mononucleares/metabolismo , Subfamília B de Transportador de Cassetes de Ligação de ATP , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Fatores Etários , Idoso , Feminino , Citometria de Fluxo , Corantes Fluorescentes , Genótipo , Humanos , Hiperlipidemias/metabolismo , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , RNA Mensageiro/sangue , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rodamina 123 , Espectrometria de Fluorescência
4.
Fam Pract ; 20(1): 36-40, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12509368

RESUMO

BACKGROUND: The quality of life (QoL) of patients with chronic diseases is an important decision criterion for medical treatment, especially in primary care settings. It is known that subjective sickness feelings often cannot be correlated with objective disease criteria. OBJECTIVE: The aim of the study was to determine the QoL of patients with intermittent claudication with the arterial morphology, haemodynamic parameters and functional disability of peripheral arterial occlusive disease (PAOD). METHODS: In 150 patients with stable intermittent claudication, the health-related QoL was compared with the angiogram score, the resting Doppler pressure values, and the initial claudication distance (ICD) and absolute claudication distance (ACD) with treadmill exercise. RESULTS: The QoL did not correlate significantly with either the angiogram score or the ankle systolic blood pressure and ankle brachial index. ICD and ACD correlated significantly with the QoL activity subscales of pain, complaints and functional status (P < 0.001). In a multiple regression analysis, ACD and body mass index were the most predictive variables for the QoL. CONCLUSION: The QoL of PAOD patients is independent of the peripheral Doppler pressure and the angiographic severity of the disease. The most important criterion for the QoL is the patient's functional disability.


Assuntos
Claudicação Intermitente , Qualidade de Vida , Afeto , Idoso , Índice de Massa Corporal , Medicina de Família e Comunidade , Feminino , Indicadores Básicos de Saúde , Hemodinâmica , Humanos , Claudicação Intermitente/diagnóstico por imagem , Claudicação Intermitente/fisiopatologia , Modelos Lineares , Masculino , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...